An overview of Ebola virus disease
- PMID: 28058346
- PMCID: PMC5175058
- DOI: 10.14744/nci.2015.97269
An overview of Ebola virus disease
Abstract
Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush meat. EVD has an incubation period of 2 to 21 days, and the infection has an acute onset without any carrier status. Currently, there is no standard treatment for EVD, so it is important to avoid infection or further spreading of the virus. Although historically the mortality of this infection exceeded 80%, modern medicine and public health measures have been able to lower this figure and reduce the impact of EBOV on individuals and communities. Its treatment involves early, aggressive supportive care with rehydration. Clinicians should consider the possibility of EVD in persons with travel or exposure history with the incubation period presenting constitutional symptoms in order to promptly identify diseased patients, and prevent further spreading of the disease.
Keywords: Ebola virus disease; diagnosis; epidemiology; treatment.
Conflict of interest statement
No conflict of interest was declared by the authors.
Similar articles
-
Overview of Ebola virus disease in 2014.J Chin Med Assoc. 2015 Jan;78(1):51-5. doi: 10.1016/j.jcma.2014.11.007. Epub 2014 Dec 26. J Chin Med Assoc. 2015. PMID: 25547820 Review.
-
The emergence of ebola as a global health security threat: from 'lessons learned' to coordinated multilateral containment efforts.J Glob Infect Dis. 2014 Oct;6(4):164-77. doi: 10.4103/0974-777X.145247. J Glob Infect Dis. 2014. PMID: 25538455 Free PMC article.
-
Ebola Virus Infection: Overview and Update on Prevention and Treatment.Infect Dis Ther. 2015 Dec;4(4):365-90. doi: 10.1007/s40121-015-0079-5. Epub 2015 Sep 12. Infect Dis Ther. 2015. PMID: 26363787 Free PMC article.
-
Ebola Virus Disease: essential public health principles for clinicians.West J Emerg Med. 2014 Nov;15(7):728-31. doi: 10.5811/westjem.2014.9.24011. Epub 2014 Sep 26. West J Emerg Med. 2014. PMID: 25493109 Free PMC article.
-
Ebola outbreak in Western Africa 2014: what is going on with Ebola virus?Clin Exp Vaccine Res. 2015 Jan;4(1):17-22. doi: 10.7774/cevr.2015.4.1.17. Epub 2015 Jan 30. Clin Exp Vaccine Res. 2015. PMID: 25648530 Free PMC article. Review.
Cited by
-
Advances and insights in the diagnosis of viral infections.J Nanobiotechnology. 2021 Oct 30;19(1):348. doi: 10.1186/s12951-021-01081-2. J Nanobiotechnology. 2021. PMID: 34717656 Free PMC article. Review.
-
Community perspectives of Ebola Viral Disease in high-risk transmission border regions of Tanzania: a qualitative inquiry.BMC Public Health. 2024 Oct 10;24(1):2766. doi: 10.1186/s12889-024-20305-2. BMC Public Health. 2024. PMID: 39390413 Free PMC article.
-
Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro.Mol Ther Nucleic Acids. 2019 Jun 7;16:686-697. doi: 10.1016/j.omtn.2019.04.018. Epub 2019 Apr 25. Mol Ther Nucleic Acids. 2019. PMID: 31125846 Free PMC article.
-
A Framework for Assessing the Impact of Outbreak Response Immunization Programs.Diseases. 2024 Apr 4;12(4):73. doi: 10.3390/diseases12040073. Diseases. 2024. PMID: 38667531 Free PMC article.
-
Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques.Lancet Microbe. 2023 Mar;4(3):e171-e178. doi: 10.1016/S2666-5247(23)00001-0. Epub 2023 Feb 2. Lancet Microbe. 2023. PMID: 36739878 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources